Literature DB >> 15706282

New drugs 05, part I.

Daniel A Hussar1.   

Abstract

In this article, you'll learn about nine new drugs, including: Prussian blue, which could protect people from radiation exposure following an act of biochemical terrorism. Bevacizumab, a new monoclonal antibody and the first angiogenesis inhibitor for colorectal cancer. Cinacalcet HCl, the first calcimimetic drug for treating hyperparathyroidism. Unless otherwise specified, the information in the following summaries applies to adults, not children. Consult the package insert for information about each drug's safety during pregnancy and breast-feeding. Also consult the package insert, a pharmacist, or a comprehensive drug reference for more details on precautions, drug interactions, and adverse reactions for all these drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15706282     DOI: 10.1097/00152193-200502000-00041

Source DB:  PubMed          Journal:  Nursing        ISSN: 0360-4039


  4 in total

Review 1.  Pharmacological management of ionizing radiation injuries: current and prospective agents and targeted organ systems.

Authors:  Vijay K Singh; Thomas M Seed
Journal:  Expert Opin Pharmacother       Date:  2020-01-11       Impact factor: 3.889

2.  Pregnancy in end-stage renal disease patients on dialysis: how to achieve a successful delivery.

Authors:  Gianfranco Manisco; Marcello Potì'; Giuseppe Maggiulli; Massimo Di Tullio; Vincenzo Losappio; Luigi Vernaglione
Journal:  Clin Kidney J       Date:  2015-03-19

Review 3.  Medical Countermeasures for Radiation Exposure and Related Injuries: Characterization of Medicines, FDA-Approval Status and Inclusion into the Strategic National Stockpile.

Authors:  Vijay K Singh; Patricia L P Romaine; Thomas M Seed
Journal:  Health Phys       Date:  2015-06       Impact factor: 1.316

4.  Anti-Fn14-Conjugated Prussian Blue Nanoparticles as a Targeted Photothermal Therapy Agent for Glioblastoma.

Authors:  Nicole F Bonan; Debbie K Ledezma; Matthew A Tovar; Preethi B Balakrishnan; Rohan Fernandes
Journal:  Nanomaterials (Basel)       Date:  2022-08-01       Impact factor: 5.719

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.